ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
May 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
June 2026
Nuclear Technology
Fusion Science and Technology
Latest News
Reimagining nuclear materials for the future of medicine
Nuclear medicine has come a long way since Henri Becquerel first observed the penetrating energy of radioactive materials in 1896. Today, technetium-99m alone is used in more than 40 million diagnostic procedures every year—from cardiovascular imaging and bone scans to cancer detection—making it the undisputed workhorse of nuclear medicine. That single statistic tells you something important: An enormous portion of modern diagnostic medicine rests on a surprisingly narrow foundation, one built around a small number of aging research reactors that were never originally designed for continuous isotope production.
Didier De Bruyn, Hamid Aït Abderrahim, Peter Baeten, Carmen Angulo (SCK-CEN)
Proceedings | 2018 International Congress on Advances in Nuclear Power Plants (ICAPP 2018) | Charlotte, NC, April 8-11, 2018 | Pages 1066-1073
Since 1998 SCK•CEN is developing the MYRRHA project as an accelerator driven system (ADS) based on the lead-bismuth eutectic (LBE) as a coolant of the reactor and a material for its spallation target. MYRRHA is a flexible fast-spectrum pool-type research irradiation facility, also serving since the FP5 EURATOM framework as the backbone of the Partitioning & Transmutation (P&T) strategy of the European Commission concerning the ADS development in the third pillar of this strategy. MYRRHA is proposed to the international community of nuclear energy and nuclear physics as a pan-European large research infrastructure in ESFRI to serve as a multipurpose fast spectrum irradiation facility for various fields of research. In this paper, we present the current implementation strategy of MYRRHA, its revised planning and some recent developments related to the accelerator.